Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 11/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22316412 | 0.89 | MAPK14 (0.44) | KCNH2KDM4EALDH1A1MAPTTSHR | |
| SCHEMBL30872068 | 0.89 | KCNH2 (0.53) | KCNH2EGLN2KDM4EALDH1A1MAPT | |
| SCHEMBL24791485 | 0.89 | KCNH2 (0.53) | KCNH2EGLN2KDM4EALDH1A1MAPT | |
| SCHEMBL22317010 | 0.83 | EGLN2 (0.43) | EGLN2GRM5CYP11B1CYP11B2 | |
| SCHEMBL22315753 | 0.81 | FFAR1 (0.38) | EGLN2KDM4EALDH1A1MAPTTSHR | |
| SCHEMBL22316413 | 0.81 | SQOR (0.38) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL16945599 | 0.80 | KCNH2 (0.41) | KCNH2EGLN2KDM4EALDH1A1MAPT | |
| SCHEMBL16945583 | 0.80 | KCNH2 (0.41) | KCNH2EGLN2KDM4EALDH1A1MAPT | |
| SCHEMBL24017201 | 0.80 | METAP2 (0.49) | KCNH2KDM4EALDH1A1MAPTTSHR | |
| SCHEMBL22315754 | 0.79 | NISCH (0.40) | EGLN2KDM4EALDH1A1MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785839-B2 | Organic light-emitting materials containing cyano-substituted ligand | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-20200251666-A1 | ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200251666-A1 | ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND | L1CAM, CYBA, ICOSLG | KCNH2 86/4885EGLN2 4787/4885KDM4E 1510/4885 |
| US-11785839-B2 | Organic light-emitting materials containing cyano-substituted ligand | L1CAM, CYBA, ICOSLG | KCNH2 86/4885EGLN2 4787/4885KDM4E 1510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.